Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 11/30 07:21:34 am
336.85 USD   -7.08%
07:00aOmicron, found in Europe 11 days ago, jolts markets on vaccine fears
RE
06:35aMarketScreener's World Press Review - November 30, 2021
06:18aEUROPEAN MIDDAY BRIEFING - Moderna CEO Comments -2-
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Biontech : Pfizer Seek European Medicines Agency's Approval for COVID-19 Vaccine for Younger Children

10/15/2021 | 10:06am EST


© MT Newswires 2021
All news about BIONTECH SE
07:00aOmicron, found in Europe 11 days ago, jolts markets on vaccine fears
RE
06:35aMarketScreener's World Press Review - November 30, 2021
06:18aEUROPEAN MIDDAY BRIEFING - Moderna CEO Comments -2-
DJ
06:14aSOCIAL BUZZ : Wallstreetbets Stocks Mostly Trading Lower Ahead of Tuesday Opener
MT
06:07aNORTH AMERICAN MORNING BRIEFING :
DJ
06:07aNORTH AMERICAN MORNING BRIEFING : -2-
DJ
05:05aCrude Oil Rebounds Sharply as Concerns Over New Coronavirus Variant Eases, ANZ Bank Say..
MT
04:28aNorwegians should wear face masks in crowded places, PM says
RE
04:27aFDA May Authorize Pfizer-BioNTech Booster Shots for Some Minors by Next Week
MT
04:16aPfizer-BioNTech's COVID-19 Booster Jab Nears US Approval for 16 to 17 Year Olds
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 17 474 M 19 856 M 19 856 M
Net income 2021 9 220 M 10 476 M 10 476 M
Net cash 2021 9 793 M 11 128 M 11 128 M
P/E ratio 2021 8,74x
Yield 2021 -
Capitalization 77 538 M 87 556 M 88 105 M
EV / Sales 2021 3,88x
EV / Sales 2022 3,38x
Nbr of Employees 2 800
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | BNTX | US09075V1026 | MarketScreener
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Last Close Price 321,04 €
Average target price 260,16 €
Spread / Average Target -19,0%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE344.70%87 556
GILEAD SCIENCES, INC.21.27%88 622
REGENERON PHARMACEUTICALS35.46%68 421
WUXI APPTEC CO., LTD.27.38%66 062
VERTEX PHARMACEUTICALS-19.56%48 336
BEIGENE, LTD.32.82%32 201